Advertisement

Overexpressed in colorectal carcinoma gene (OCC-1) upregulation and APPL2 gene downregulation in breast cancer specimens

  • Abolfazl Ghalaei
  • Maryam Kay
  • Shiva Zarrinfam
  • Parisa Hoseinpour
  • Mehrdad Behmanesh
  • Bahram M. Soltani
Original Article
  • 10 Downloads

Abstract

Breast cancer is the most common cancer type and the second cause of cancer death in women. Different mechanisms are contributed to the initiation and progression of the breast cancer. OCC-1 and APPL2 neighboring genes located in 12q.23.3 human chromosome region are related to colorectal cancer. Here, we intended to investigate OCC-1 newly reported transcript variants and APPL2 gene expression alteration in breast cancer specimens and investigate OCC-1 variants overexpression effect on APPL2 and on cell cycle status. Rt-qPCR analysis indicated that the expression level of OCC-1A/B and OCC-1D (not OCC-1C) transcript variants has been increased while, APPL2 gene expression level has been decreased in breast cancer specimen, compared to their normal pairs. Therefore, a negative correlation of expression is evident between APPL2 and OCC-1 genes in breast cancer specimen. Unlike OCC-1A/B which encodes a small protein, OCC-1D noncoding RNA overexpression lead to APPL2 downregulation in MCF7 cells. Consistently, OCC-1D overexpression resulted in increased sub-G1 cell population in MCF7 cells, detected by flow cytometry. Altogether, these results suggest that OCC1-D variant have an inhibitory effect on APPL2 expression and may regulate the cell cycle status.

Keywords

Breast cancer OCC-1 gene APPL2 

Notes

Acknowledgements

This work was supported by INSF financial aids.

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

This study was approved by the Clinical Research Ethics Committee of Iranian Breast Cancer Research Center.

References

  1. 1.
    Weigelt B, Peterse JL, Van’t Veer LJ (2005) Breast cancer metastasis: markers and models. Nat Rev Cancer 5:591–602CrossRefPubMedGoogle Scholar
  2. 2.
    Shukla A, Alsarraj J, Hunter K (2014) Understanding susceptibility to breast cancer metastasis: the genetic approach. Breast Cancer Manage 3:165–172CrossRefGoogle Scholar
  3. 3.
    Wang K, Li J, Xiong Y-F, Zeng Z, Zhang X, Li H-Y (2018) A Potential prognostic long noncoding RNA signature to predict recurrence among ER-positive breast cancer patients treated with tamoxifen. Sci Rep 8:3179CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Zhang Q, Wei Y, Yan Z, Wu C, Chang Z, Zhu Y, Li K, Xu Y (2017) The characteristic landscape of lncRNAs classified by RBP–lncRNA interactions across 10 cancers. Mol Biosyst 13:1142–1151CrossRefPubMedGoogle Scholar
  5. 5.
    Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100:57–70CrossRefPubMedGoogle Scholar
  6. 6.
    van’t Veer LJ (2006) Molecular profiles guide the way to improve patient management. Clin Cancer Res 12:PL–P36-PL-36Google Scholar
  7. 7.
    Pibouin L, Villaudy J, Ferbus D, Muleris M, Prospéri M-T, Remvikos Y, Goubin G (2002) Cloning of the mRNA of overexpression in colon carcinoma-1: a sequence overexpressed in a subset of colon carcinomas. Cancer Genet Cytogenet 133:55–60CrossRefPubMedGoogle Scholar
  8. 8.
    Najafi H, Soltani BM, Dokanehiifard S, Nasiri S, Mowla SJ (2017) Alternative splicing of the OCC-1 gene generates three splice variants and a novel exonic microRNA, which regulate the Wnt signaling pathway. RNA 23:70–85CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Kikuchi K, Fukuda M, Ito T, Inoue M, Yokoi T, Chiku S, Mitsuyama T, Asai K, Hirose T, Aizawa Y (2009) Transcripts of unknown function in multiple-signaling pathways involved in human stem cell differentiation. Nucleic Acids Res 37:4987–5000CrossRefPubMedPubMedCentralGoogle Scholar
  10. 10.
    Miaczynska M, Christoforidis S, Giner A, Shevchenko A, Uttenweiler-Joseph S, Habermann B, Wilm M, Parton RG, Zerial M (2004) APPL proteins link Rab5 to nuclear signal transduction via an endosomal compartment. Cell 116:445–456CrossRefGoogle Scholar
  11. 11.
    Rashid S, Pilecka I, Torun A, Olchowik M, Bielinska B, Miaczynska M (2009) Endosomal adaptor proteins APPL1 and APPL2 are novel activators of β-catenin/TCF-mediated transcription. J Biol Chem 284:18115–18128CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Pyrzynska B, Banach-Orlowska M, Teperek-Tkacz M, Miekus K, Drabik G, Majka M, Miaczynska M (2013) Multifunctional protein APPL2 contributes to survival of human glioma cells. Mol Oncol 7:67–84CrossRefPubMedGoogle Scholar
  13. 13.
    Soule H, Vazquez J, Long A, Albert S, Brennan M (1973) A human cell line from a pleural effusion derived from a breast carcinoma. J Natl Cancer Inst 51:1409–1416CrossRefPubMedGoogle Scholar
  14. 14.
    Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2−∆∆CT method. methods 25:402–408CrossRefPubMedGoogle Scholar
  15. 15.
    Guil S, Esteller M (2012) Cis-acting noncoding RNAs: friends and foes. Nat Struct Mol Biol 19:1068–1075CrossRefPubMedGoogle Scholar
  16. 16.
    Yeo JC, Wall AA, Luo L, Stow JL (2015) Rab31 and APPL2 enhance FcγR-mediated phagocytosis through PI3K/Akt signaling in macrophages. Mol Biol Cell 26:952–965CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Chang F, Lee J, Navolanic P, Steelman L, Shelton J, Blalock W, Franklin R, McCubrey J (2003) Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy. Leukemia 17:590CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  • Abolfazl Ghalaei
    • 1
  • Maryam Kay
    • 1
  • Shiva Zarrinfam
    • 1
  • Parisa Hoseinpour
    • 2
  • Mehrdad Behmanesh
    • 1
  • Bahram M. Soltani
    • 1
  1. 1.Genetics DeptartmentTarbiat Modares UniversityTehranIran
  2. 2.Breast Cancer Research CenterACECRTehranIran

Personalised recommendations